申请人:Pfizer Inc.
公开号:US08318762B2
公开(公告)日:2012-11-27
The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R1, R2, and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of acetyl-CoA carboxylase enzyme(s) in an animal.
本发明提供了公式(1)的化合物或其药学上可接受的盐,其中R1、R2和R3如本文所述;其制备的药物组合物;以及在动物体内抑制乙酰辅酶A羧化酶酶(s)的作用下调节的疾病、状况或疾患的治疗中使用它们的方法。